Stock LJPC LA JOLLA PHARMACEUTICAL COMPANY
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases La Jolla Pharmaceutical Company

Equities

LJPC

US5034596040

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
PU
La Jolla Pharmaceutical : Statement of Changes in Beneficial Ownership - Form 4
PU
La Jolla Pharmaceutical : Termination of a Material Definitive Agreement - Form 8-K
PU
LA JOLLA PHARMACEUTICAL CO : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
LA JOLLA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
LA JOLLA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of La Jolla Pharmaceutical Company - LJPC
BU
Twitter, Las Vegas Sands fall; Mullen, La Jolla rise
AQ
La Jolla Pharmaceutical : Innoviva to Acquire La Jolla Pharmaceutical Company - Form 8-K
PU
LA JOLLA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
Innoviva to Acquire La Jolla Pharmaceutical Company
BU
La Jolla Pharmaceutical: Q1 Earnings Snapshot
AQ
LA JOLLA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Corporate Progress
BU
La Jolla Pharmaceutical : Corporate Presentation March 2022
PU
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2021 and Highlights Corporate Progress
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LJPC Stock
  4. News La Jolla Pharmaceutical Company
  5. Press Releases